Correlation of precancerous lesion incidence with duodenogastric reflux and N-nitroso compound duration at reflux and antireflux stomach surgery – An experimental study

  • Aleksandar Zlatić Clinical Center Niš, General Surgery Clinic, Niš, Serbia
  • Mirjana Marinković Clinical Center Niš, General Surgery Clinic, Niš, Serbia
  • Dragan Mihailović University of Niš, Faculty of Medicine, Niš, Serbia
  • Milan Radojković Clinical Center Niš, General Surgery Clinic, Niš, Serbia
  • Biljana Dinić-Radovanović University of Niš, Faculty of Medicine, Niš, Serbia
  • Miodrag Djordjević Clinical Center Niš, General Surgery Clinic, Niš, Serbia
  • Milan Korica University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Radovan Veljković University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
Keywords: duodenogastric reflux;, gastric mucosa;, precancerous condi¬tions;, stomach neoplasms;, nitroso compounds;, digestive system surgical procedures;, disease model, animal;, rats.

Abstract


Background/Aim. Duodenogastric reflux occurs after gastroenteroanastomosis, with or without resection of the stomach (Billroth I, Billroth II), after vagotomy and pyloroplasty, gastroduodenostomy as well as in conser­vatively treated patients. The aim of this study was to analyse the effect of carcinogenic N-nitroso compounds (MNNG) influence in conjunction with duodenogastric reflux, in the function of time for precancerous lesions development in gastric mucosa. A particular purpose of the study has been to suggest some effective surgical procedures, which could prevent the harmful effects of duodenogastric reflux on gastric mucosa, as a potential activator of carcinogenesis. Methods. The research in­cluded 90 experimental, male Wistar rats, divided into 3 groups. The two experimental groups were subjected to two surgical procedures: Billroth II gastric resection (group B2), and the Roux-en-Y reconstruction (group RY), respectively. The control group (group C) animals did not receive any surgical treatment. All groups were administered per os chemical cancerogen MNNG. All anastomoses were performed by extra mucosal suture with monofilament polypropilene 7–0, and 8–0. The animals were sacrificed consecutively, and subjected to total gastrectomy after 8, 16 and 24 weeks. Results. Pathohistological analysis was performed on defined re­gions of the rat stomach in three time period. The B2 group, at the end of our experiment, showed predomi­nant incidence of severe lesions: hyperplasia (0%), gastri­tis (0%), metaplasia (6.7%), dysplasia (46.7%), early car­cinoma (20%) and carcinoma (26.7%). At the end of our experiment, the RY and C groups showed the similari­ties of the obtained results related to time with pre­dominant incidence of mild lesions: hyperplasia (13.3% vs 0%, respectively), gastritis (13.3% vs 13.3%, respec­tively), metaplasia (6.7% vs 13.3%, respectively), dyspla­sia (66.7% vs 66.7%, respectively), with an extremely low incidence of early carcinoma (0% vs 6.7%, respec­tively) and no incidence of carcinoma (0% vs 0%, respec­tively). Conclusion. Without the presence of duode­nogastric reflux, MNNG causes a low degree of precan­cerous gastric lesions. However, direct contacts of MNNG with gastric mucosa, including the presence of duodenogastric reflux, induce precancerous lesions and carcinoma. The percentage of reversible changes de­creases with time, while the percentage of irreversible lesions and carcinoma increases. A lack of distinction in the findings between the RY and C groups confirms a gastroprotective role of the Roux-en-Y procedure.

References

REFERENCE

Ichikawa D, Komatsu S, Kosuga T, Konishi H, Okamoto K, Shiozaki A, et al. Clinicopathological characteristics of clinical early gastric cancer in the upper-third stomach. World J Gastroen-terol 2015; 21(45): 12851–6.

Ohira M, Toyokawa T, Sakurai K, Kubo N, Tanaka H, Mugu¬ruma K, et al. Current status in remnant gastric can¬cer after distal gastrectomy. World J Gastroenterol 2016; 22(8): 2424–33.

Nomura E, Lee S, Tokuhara T, Nitta T, Kawai M, Uchiyama K. Functional outcomes according to the size of the gastric rem-nant and the type of reconstruction following distal gastrec-tomy for gastric cancer : an investigation including total gas-trectomy. Jpn J Clin Oncol 2013; 43(12): 1195–202.

Zlatić A, Stojanović M, Mihailović D, Radovanović-Dinić B, Protić M, Veljković R. The role of duodenogastric reflux in formation of precarcinogenic gastric lesions: An experi¬mental study. Med Pregl 2013; 66(7–8): 285–29. (Serbian)

Rugge M, Capelle LG, Fassan M. Individual risk stratifica¬tion of gastric cancer : evolving concepts and their impact on clini-cal practice. Best Pract Res Clin Gastroenterol 2014; 28(6): 1043–53.

Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, Oue N. Mo-lecular pathology of gastric cancer : research and practice. Pathol Res Pract 2011; 207(10): 608–12.

Forman D, Burley VJ. Gastric cancer: global pattern of the dis-ease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006; 20(4): 633–49.

Motohashi M, Wakui S, Muto T, Suzuki Y, Shirai M, Takaha¬shi H, et al. Cyclin D1/cdk4, estrogen receptors α and β, in N-methyl-N′-nitro-N-nitrosoguanidine-induced rat gastric car-cinogenesis: Immunohistochemical study. J Toxicol Sci 2011; 36(3): 373–8.

Tomita H, Kuno T, Yamada Y, Oyama T, Asano N, Miya¬zaki Y, et al. Preventive effect of fermented brown rice and rice bran on N-methyl-N'-nitro-N-nitrosoguanidine-in¬duced gastric car-cinogenesis in rats. Oncol Rep 2008; 19(1): 11–5.

Sharma P, Montgomery E. Gastrointestinal dysplasia. Pathol¬ogy 2013; 45(3): 273–85.

Srivastava A, Lauwers GY. Gastric epithelial dysplasia : The Western perspective. Dig Liver Dis 2008; 40(8): 641–9.

Katić V. Precancerous gastric laesions. In: Katić V, editor. Pa-thology of gaster. Belgrade, Zagreb: Medicinska knjiga; 1989. p. 73–130. (Serbian)

Takeno S, Hashimoto T, Maki K, Shibata R, Shiwaku H, Ya¬mana I, et al. Gastric cancer arising from the remnant stomach after distal gastrectomy : a review. World J Gas¬troenterol 2014; 20(38): 13734–740.

Butler A. Nitrites and nitrates in the human diet : carcino¬gens or beneficial hypotensive agents ? J Ethnopharmacol 2015; 167(5): 105–7.

Bryan NS, Alexander DD, Coughlin JR, Milkowski AL, Boffetta P. Ingested nitrate and nitrite and stomach cancer risk: An up-dated review. Food Chem Toxicol 2012; 50(10): 3646–65.

Gronnier C, Bruyère E, Piessen G, Briez N, Bot J, Buob D, et al. Operatively induced chronic reflux in rats: A suitable model for studying esophageal carcinogenesis?. Surgery 2013; 154(5): 955–67.

Klaunig JE, Wang Z, Pu X, Zhou S. Oxidative stress and oxi-dative damage in chemical carcinogenesis. Toxicol Appl Pharmacol 2011; 254(2): 86–99.

Gunassekaran GR, Priya KD, Gayathri R, Sakthisekaran D. Bio-chemical and Biophysical Research Communications In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocarcinoma (AGS) cell line and MNNG induced experimental gastric cancer. Biochem Biophys Res Commun 2011; 411(4): 661–6.

Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Envi-ronmental and chemical carcinogenesis. Semin Cancer Res 2004; 14(6): 473–86.

Øvrebø KK, Svanes K, Aase S, Grong K, Sørbye H. Duode-nogastric reflux increases the penetration of N-3H-methyl-N-nitro-N-nitrosoguanidine into the antral mucosa of rats: A possible role for mucosal erosions and increased cell prolifera-tion in gastric carcinogenesis. Jpn J Cancer Res 2002; 93(5): 484–94.

Miyashita T, Miwa K, Fujimura T, Ninomiya I, Fushida S, Shah FA, et al. The severity of duodeno-esophageal reflux influ-ences the development of different histological types of esophageal cancer in a rat model. Int J Cancer 2013; 132(7): 1496–504.

Naresse LE, Kobayashi S, Rodrigues MA. Carcinogenesis of the upper gastrointestinal tract induced by N-methyl-N' -nitro-nitrosoguanidine and reflux of duodenal contents in the rat. Acta Cir Bras 2009; 24(2): 112–7.

Monteiro RL, Andreollo NA, Rodrigues MA, Araujo MR. Gas¬tric proliferative lesions induced by duodenogastric re¬flux in rats. Acta Cir Bras 2006; 21(4): 207–13.

Aya M, Yashiro M, Nishioka N, Onoda N, Hirakawa K. Car-cinogenesis in the Remnant Stomach Following Distal Gas-trectomy with Billroth II Reconstruction is Associated with High-level Microsatellite Instability. Anticancer Res 2006; 26(2B): 1403–11.

Rodrigues PA, Kobayasi S, Rodrigues MA. Does troncular vagot-omy modify the proliferative gastric lesions induced in rats by duodenogastric reflux?. Acta Cir Bras 2007; 22(3): 210–14.

Farre R. Pathophysiology of gastro-esophageal reflux dis¬ease: a role for mucosa integrity?. Neurogastroenterol Mo¬til 2013; 25(10): 783–99.

Tatematsu M, Tsukamoto T, Toyoda T. Effects of eradica¬tion of Helicobacter pylori on gastric carcinogenesis in ex¬perimental models. J Gastroenterol 2007; 42(Suppl 17): 7–9.

Pritchard DM, Przemeck SM. Review article: How useful are the rodent animal models of gastric adenocarcinoma? Aliment Pharmacol Ther 2004; 19(8): 841–59.

Cai J, Wang M, Zhu M, Zhang Q, Zhang X, Yan Y, et al. N-methyl-N-nitro-N'-nitrosoguanidine induces the expres¬sion of CCR2 in human gastric epithelial cells promoting CCL2-mediated migration. Mol Med Rep 2016; 13(2): 1083–90.

Mihailović D. Stereological and histochemical analysis of his-togenesis of experimental gastric cancer [thesis]. Niš: Faculty of Medicine, University of Niš; 1984. (Serbian)

Xu Q, Yang CH, Liu Q, Jin XF, Xu XT, Tong JL, et al. Che-mopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosogua¬nidine (MNNG)-induced gastrointestinal cancer in rat model. J Dig Dis 2011; 12(3): 181–7.

Raphael KR, Sabu MC, Kumar KB, Kuttan R. Inhibition of N-Methyl N ' –nitro - Nitrosoguanidine (MNNG) In¬duced Gas-tric Carcinogenesis by Phyllanthus amarus Ex¬tract. Asian Pac J Cancer Prev 2006; 7(2): 299–302.

Tsukamoto H, Mizoshita T, Katano T, Hayashi N, Ozeki K, Ebi M, et al. Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Exp Toxicol Pathol 2015; 67(3): 271–7.

Kobayasi S, Tatematsu M, Ogawa K, de Camargo JL, Rodri¬gues MA, Ito N. Reversibility of adenomatous hyperplasia in the gastric stump after diversion of bile reflux in rats. Carcinogen-esis 1991; 12(8): 1437–43.

Rodrigues PA, Naresse LE, Minossi JG, Hashimoto CN. Altera-tions of the gastric stump and not resected stomach mucosa after truncal vagotomy in rats. Acta Cir Bras 2014; 29(2): 99–103.

Hoya Y, Mitsumori N, Yanaga K. The Advantages and Disad-vantages of a Roux-en-Y Reconstruction After a Dis¬tal Gas-trectomy for Gastric Cancer. Surg Today 2009; 39(8): 647–51.

Xiong J, Altaf K, Javed MA, Nunes QM, Huang W, Mai G, et al. Roux-en-Y versus Billroth I reconstruction after distal gas-trectomy for gastric cancer: A meta-analysis. World J Gastro-enterol 2013; 19(7): 1124–34.

Published
2020/12/21
Section
Original Paper